Models
AJANTA PHARMA LIMITEDAJANTPHARMPharmaceuticals & Biotechnology
1,291per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model1,291implied FY26 P/E 14.2× · EV/EBITDA 11.7×
Against CMP ₹3,559.9063.7%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY3181%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.

Where the methods land · ₹ per share · the dashed line is the CMP

DCF, rate ±1 · growth ±1your model across the sensitivity grid
9801,913
52-week rangetraded range, a fact not a value
2,3303,796

From enterprise to equity · ₹ crore

PV of FY27FY31 free cash flow3,096
PV of terminal value13,197
Enterprise value16,292
less net debt(109)
less non-controlling interest0
add non-operating investments0
Equity value16,183
÷ 12.54 crore shares1,291
81% of the value sits after FY31. Usual when return on capital sits near the cost of capital; the 5 explicit years carry little of it.

Free cash flow, filed and modelled · ₹ '000 crore

0112FY21: ₹405 croreFY21FY22: ₹413 croreFY22FY23: ₹617 croreFY23FY24: ₹633 croreFY24FY25: ₹839 croreFY25FY26: ₹164 croreFY26FY27: ₹483 croreFY27FY28: ₹622 croreFY28FY29: ₹794 croreFY29FY30: ₹1,007 croreFY30FY31: ₹1,271 croreFY31
Filed, cash from operations − capexModelled free cash flow to firm

Sensitivity · ₹ per share

Down Across
WACCterminal growth4.0%4.5%5.0%5.5%6.0%
10.00%1,3361,4401,5661,7201,913
10.50%1,2261,3131,4161,5401,691
11.00%1,1321,2051,2911,3921,514
11.50%1,0511,1131,1851,2691,369
12.00%9801,0341,0951,1661,248
The outlined cell is your model. Green figures sit above the CMP of ₹3,559.90; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.

Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together

P10994P501,271P901,609
10th · 50th · 90th percentile, ₹ per share994 · 1,271 · 1,609
Draws below the CMP100%
Rank correlation with ebitda margin+0.81
Rank correlation with discount rate0.51
Rank correlation with revenue growth+0.16
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.

Projected cash flow to the firm · ₹ crore

History Forward
₹ croreFY23FY24FY25FY26FY27FY28FY29FY30FY31
Revenue3,7434,2094,6485,4536,4077,5288,84610,39412,213
growth %12.012.510.417.317.517.517.517.517.5
EBITDA7831,1721,2601,3951,6401,9272,2652,6613,126
margin %20.927.827.125.625.625.625.625.625.6
less depreciation(131)(135)(144)(173)(205)(241)(283)(333)(391)
EBIT6521,0371,1151,2221,4351,6861,9812,3282,736
less tax on EBIT(285)(334)(393)(462)(542)(637)
NOPAT9371,1011,2931,5201,7862,098
add depreciation131135144173205241283333391
less capex(174)(152)(318)(365)(429)(451)(466)(473)(469)
less working-capital build(393)(462)(543)(638)(749)
Free cash flow to firm6176338394836227941,0071,271
Discount factor0.9490.8550.7700.6940.625
Present value459532612699794
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.

The three statements, projected · ₹ crore · debt held at 212, dividends at 33.1% of profit

₹ croreFY26FY27FY28FY29FY30FY31
Income statement
EBIT1,2221,4351,6861,9812,3282,736
Interest at 15% on debt(32)(32)(32)(32)(32)
Profit before tax1,4031,6551,9502,2962,704
Profit after tax1,0561,0761,2691,4951,7612,074
Dividends(350)(356)(420)(495)(583)(686)
Balance sheet, year end
Cash1032063836581,0581,617
Working capital2,2482,6423,1033,6464,2845,033
Net block and other assets3,8034,0274,2374,4204,5614,639
Debt212212212212212212
Equity4,5275,2476,0967,0978,2759,662
Balance check000(0)(0)0
Cash flow
From operations8881,0481,2361,4561,715
Investing (capex)(429)(451)(466)(473)(469)
Financing (dividends)(356)(420)(495)(583)(686)
Net change in cash103177275400560
Free cash flow to equity4595977699831,246
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.

Scenarios side by side · ₹ per share

ScenarioTemplateGrowthMarginRateTerminal₹ / sharevs CMP
Base · editingDCF17.5%25.6%11.00%5%1,291(63.7)%
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.